Characterization of Collapsin Response Mediator Protein 2 in Colorectal Cancer Progression in Subjects with Diabetic Comorbidity
Authors:
- Yih-Hsin ChangYCYih-Hsin Chang
- Hui-Ju YangHYHui-Ju Yang
- Huan-Wen ChenHCHuan-Wen Chen
- Chiao-Wan HsiaoCHChiao-Wan Hsiao
- Yi-Chen HsiehYHYi-Chen Hsieh
- Yu-Wei ChanYCYu-Wei Chan
- Shu-Wen ChangSCShu-Wen Chang
- Wei-Lun HwangWei-Lun Hwang
- Wei-Shone ChenWCWei-Shone Chen
- Hou-Hsuan ChengHCHou-Hsuan Cheng
- Teh-Ying ChouTCTeh-Ying Chou
- Fu-Pang ChangFCFu-Pang Chang
Open Access
Abstract
Background: Common demographic risk factors are identified in colorectal cancer (CRC) and type 2 diabetes mellitus (DM), nevertheless, the molecular link and mechanism for CRC-DM comorbidity remain elusive. Dysregulated glycogen synthase kinase-3 beta under metabolic imbalance is suggested to accelerate CRC pathogenesis/progression via regulating collpasin response mediator protein-2 (CRMP2). Accordingly, roles of CRMP2 in CRC and CRC-DM patients were investigated for elucidating the molecular convergence of CRC and DM. Methods: CRMP2 profile in tumor tissues from CRC and CRC-DM patients was investigated to explore the link between CRC and DM etiology. Meanwhile, molecular mechanism of glucose to regulate CRMP2 profile and CRC characteristics was examined in vitro and in vivo. Results: CRMP2 was significantly lower in tumor lesions and associated with advanced tumor stage in CRC-DM patients. Physiological hyperglycemia suppressed CRMP2 expression/activity and augmented malignant characteristics of CRC cells. Hyperglycemia promotes actin de-polymerization, cytoskeleton flexibility and cell proliferation/metastasis by downregulating CRMP2 profile and thus contributes to CRC disease progression. Conclusions: This study uncovers molecular evidence to substantiate and elucidate the link between CRC and T2DM, as well as characterizing the roles of CRMP2 in CRC-DM. Accordingly, altered metabolic adaptations are promising targets for anti-diabetic and cancer strategies.Keywords
Funding Information
- Ministry of Science and Technology Taiwan (MOST 102-2320-B-241-004-MY3, 105-2320-B-241-005 and 110-2314-B-241-001)
- National Yang-Ming University Far Eastern Memorial Hospital Joint Research Program (109DN14 and 110DN17)
- Veterans General Hospitals and University System of Taiwan Joint Research Program (VGHUST106-G7-7-1, 108-G2-1-1, 109-V7-3 and 110-G2-2-3)
This publication has 40 references indexed in Scilit:
- Phosphorylated tubulin adaptor protein CRMP‐2 as prognostic marker and candidate therapeutic target for NSCLCInternational Journal of Cancer, 2012
- Non-glucose metabolism in cancer cells—is it all in the fat?Cancer and Metastasis Reviews, 2012
- SNAIL Regulates Interleukin-8 Expression, Stem Cell–Like Activity, and Tumorigenicity of Human Colorectal Carcinoma CellsGastroenterology, 2011
- Metabolic alterations and targeted therapies in prostate cancerThe Journal of Pathology, 2010
- Identification of collapsin response mediator protein‐2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomesProteomics, 2008
- Evidence for a role of Collapsin response mediator protein-2 in signaling pathways that regulate the proliferation of non-neuronal cellsBiochemical and Biophysical Research Communications, 2006
- GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal PolarityCell, 2005
- α2-Chimaerin, Cyclin-Dependent Kinase 5/p35, and Its Target Collapsin Response Mediator Protein-2 Are Essential Components in Semaphorin 3A-Induced Growth-Cone CollapseJournal of Neuroscience, 2004
- Role of CRMP‐2 in neuronal polarityJournal of Neurobiology, 2003
- CRMP-2 binds to tubulin heterodimers to promote microtubule assemblyNature Cell Biology, 2002